Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01558 HEC CJ PHARM
RT Nominal down9.980 -0.040 (-0.399%)
Latest  |  Final  |  Interim
Non-current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties----0000
Property, plant, equip. & others----3,398,3693,169,6132,858,8082,489,661
Land & other Lease Assets----342,055349,152357,747346,045
Intangible Assets----2,565,6262,920,6463,347,8862,785,487
Interests in Asso. & JCEs----12,571000
Other Non-current Assets----372,652436,3691,919,764675,964

----6,691,2736,875,7808,484,2056,297,157
Current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories----409,050315,027279,696378,268
Trade Receivables----2,072,6111,005,817479,041460,509
Cash & Bank Balances----1,674,413923,5431,131,1212,044,967
Other Current Assets----1,896,982457,313167,518380,366
Assets Held for Sale----02,312,32000

----6,053,0565,014,0202,057,3763,264,110
Current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables----200,088167,387115,322239,551
S-T Debt & Leases----2,319,8773,130,30648,4772,820,804
Other Current Liabilities----1,812,2551,643,0881,074,2651,100,858
Liab asso w/ Assets Held for Sale----0000

----4,332,2204,940,7811,238,0644,161,213
Net Current Assets----1,720,83673,239819,312(897,103)
Total Assets Less Current Liabilities----8,412,1096,949,0199,303,5175,400,054
Non-current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases----289,451691,5293,145,025189,853
Other Non-current Liabilities----187,145187,489137,730106,542

----476,596879,0183,282,755296,395
Capital and Reserves
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital----879,968879,968879,968879,968
  Reserves----7,055,5455,004,9164,928,3134,011,135
  Others----0000
Shareholders' Funds----7,935,5135,884,8845,808,2814,891,103
Non-controlling Interests----0185,117212,481212,556
Others----0000

----7,935,5136,070,0016,020,7625,103,659
Commitments and Contingent Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----1,995,1741,876,1992,121,0642,201,644
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 03/04/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 482,712,000
%Change-75.775%
EPS / (LPS)RMB 0.550
NBV Per Share (¥)RMB --
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.